PHG vs PRCT Stock Comparison

PHG currently leads PRCT in this stock comparison, with AIQ scores of 72 vs 49. The clearest difference is value.

Market data as of Nov 18, 2026 market close· AIQ score gap 23 points
PHG
Healthcare
vs
PRCT
Healthcare
PHG
Koninklijke Philips N.V.
Leads
Price
$29.81
Day move
-0.27%
AIQ Score
72/100
Best edge
Value
Sector
Healthcare
PRCT
PROCEPT BioRobotics Corporation
Price
$25.18
Day move
+5.89%
AIQ Score
49/100
Best edge
Balanced
Sector
Healthcare

What is the main difference between PHG and PRCT?

PHG leads the current stock comparison as Koninklijke Philips N.V., with the clearest separation coming from value and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Koninklijke Philips N.V. vs PROCEPT BioRobotics Corporation

Data as of Nov 18, 2026· market close· Healthcare· Coverage 61/66 fields· High confidence
AIQ VerdictCompetitiveAIQ Comparison Conviction 8/10

PHG leads

PHG leads by 23 AIQ points, primarily on Value and Risk Resilience, and the lead has widened from 18 points over 30 sessions.

Competitive: 3 of 5 evidence groups support PHG, its lead is widening, and its current signal state is conflicted.

Evidence agreement: 3 of 5Comparison trend: Strengthening
PHG

Koninklijke Philips N.V.

Leads
AIQ Score
72/100
AIQ Edge Score
10/10
PRCT

PROCEPT BioRobotics Corporation

AIQ Score
49/100
AIQ Edge Score
5/10

The Algovestiq AIQ Score currently favors PHG over PRCT, 72 versus 49 as of Nov 18, 2026. PHG's advantage is driven primarily by stronger value and risk resilience. PHG also shows the weaker technical structure relative to its 50-day moving average. 3 of 5 covered evidence groups favor PHG today, and the comparison is rated Competitive on stability: the leader is throwing conflicting signals. PHG lead: Strengthening — the AIQ differential moved from 18 to 23 points over 30 sessions. PHG leads on all four AIQ factor dimensions. Value is itself one of those four, so a sweep is not explained by valuation alone — it deserves additional scrutiny for unmodeled catalysts, expectations or event risk.

Compare Koninklijke Philips N.V. and PROCEPT BioRobotics Corporation across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Total return with distributions reinvested, from daily closes.

PHG
-11.1%
PRCT
-37.1%

Total return comparison

Growth of $10,000, distributions reinvested

PHG $8,887 · PRCT $6,293

Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.

Compare PHG and PRCT against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

PHG advantage
0
PRCT advantage
  • Value80 vs 38
    PHG +42
  • Risk Resilience73 vs 45
    PHG +28
  • Quality67 vs 45
    PHG +22
  • Momentum72 vs 60
    PHG +12

3 of 5 evidence groups favor PHG. PHG’s edge is concentrated in value and risk resilience.

What changed since the last close

Latest scored session 2026-11-18, compared against the prior scored session 2026-11-17.

PHG0 AIQ

Largest factor move: Value +1, not enough on its own to move the overall score.

New signals

  • RSI Overbought — bearish, momentum, short horizon
PRCT0 AIQ

Largest factor move: Value -1, not enough on its own to move the overall score.

New signals

  • Accumulation Pattern — bullish, volume, medium horizon (1.27x)

PHG's lead was unchanged in the latest session.

Deeper signal detail for each name lives on its own signals page — PHG and PRCT both carry a full feed there.

The central trade-off

PHG (Koninklijke Philips N.V.): the stronger current systematic profile, led by value and risk resilience.

PRCT (PROCEPT BioRobotics Corporation): the counter-case, on fundamentals, technicals — but at materially higher volatility, 64% against 38.9%.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

PHG

PHG on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

PRCT

PRCT on combined revenue and EPS growth.

Value

PHG

PHG on the peer-relative Value factor, by 42 points.

Momentum

PHG

PHG on the Momentum factor, by 12 points.

Lower downside

PHG

PHG on Risk Resilience, by 28 points.

Analyst upside

Even

Analyst targets are level or not covered for both names.

AIQ vs Wall Street

Where the systematic read and the analyst consensus line up — and where they do not.

MeasurePHGPRCTNote
Implied upside to target—+19.1%Level
Target dispersion—0%Lower is tighter analyst agreement
ConsensusBuyHoldContext, not a primary driver
Analysts covering515Higher coverage generally improves confidence

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

3 of 5 covered evidence groups favor PHG. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScorePHG72 vs 49
FundamentalsPRCTon balanceEPS growth -93.1% vs 2.1%; gross margin 46.4% vs 64.7%; operating margin 10.9% vs -33.6% — PRCT takes 2 of 3 decided legs, not all of them
ValuationPHGValue 80 vs 38
TechnicalsPRCTPrice vs 50-day 14% vs 29%; vs 200-day 11.4% vs 3.9%
Risk ResiliencePHGRisk Resilience 73 vs 45
Analyst expectationsNot coveredNot covered

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of PHG and PRCT and are excluded from the count.

AIQ Decision Stability

Competitive

The two are close enough that your objective, not the score, should decide.

  • The AIQ gap is wide at 23 points. (supports the conclusion holding)
  • The leader's advantage has been widening. (supports the conclusion holding)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on PHG.

How the comparison changed

120 daily snapshots · Jun 1 – Nov 18

PHG lead: Strengthening — the AIQ differential moved from 18 to 23 points over 30 sessions.

Jun 1PHG leads above the line · PRCT leads belowNov 18
Today
PHG +23
72 vs 49
7 sessions ago
PHG +27
73 vs 46
30 sessions ago
PHG +18
63 vs 45
90 sessions ago
PHG +21
60 vs 39

The lead has not changed hands in this window.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

PHGConflicted

3 bullish / 2 bearish / 1 neutral, conflicted

Only PHG

  • EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
  • RSI Overbought — bearish, momentum, short horizon
PRCTConflicted

4 bullish / 1 bearish / 2 neutral, conflicted

Only PRCT

  • ATR Expansion - Breakout Mode — neutral, volatility, short horizon (5.61%)
  • Accumulation Pattern — bullish, volume, medium horizon (1.27x)
  • MACD Histogram Expanding Bullish — bullish, momentum, short horizon

Both carry 4 more signals that do not separate them: Death Cross Active, ADX Trend Strengthening, Keltner Channel Breakout, TRIX Bullish Signal.

PHG leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

PHGNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -0.27%, AIQ 0 points).

PRCTNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +5.89%, AIQ 0 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1PRCT closes the Value gap — currently 42 points behind, the largest single contributor to PHG's edge.
  2. 2PRCT's Death Cross Active resolves — a bearish trend rule currently active against it.
  3. 3PHG's conflicting signal state resolves bearish — it currently carries 3 bullish and 2 bearish rules at once.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

PRCT leads on balance
MetricPHGPRCT
Revenue growth (YoY)0.2%4%
EPS growth (YoY)-93.1%2.1%
Gross margin46.4%64.7%
Operating margin10.9%-33.6%
Return on equity (TTM)0.2%-8.1%
Debt to equity0.70.23

Performance

PHG leads 4 of 6 windows
MetricPHGPRCT
1 week (5 sessions)0%15.4%
1 month (20 sessions)17.9%35.5%
3 months (63 sessions)13.1%12.8%
6 months (126 sessions)20.3%-8.9%
Year to date12%-24.3%
1 year (252 sessions)3.3%-22.7%

Technicals

PRCT has the stronger structure
MetricPHGPRCT
RSI (14)70.969
ADX (14)43.236.7
Price vs 50-day14%29%
Price vs 200-day11.4%3.9%
Volatility (1M, annualized)38.9%64%

Risk

PHG is the more resilient
MetricPHGPRCT
Beta0.851.01
Sharpe ratio0.18-0.11
Sortino ratio0.27-0.15
Max drawdown-27.7%-53.8%
Current drawdown-7.8%-34.1%
Annualized volatility29.7%65.9%
Value at risk (95%)-2.5%-6%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, PHG or PRCT?

On the Algovestiq AIQ Score, PHG is the stronger of the two as of Nov 18, 2026, scoring 72 against PRCT's 49. The edge comes from value and risk resilience. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is PHG or PRCT the better buy right now?

PHG carries the stronger systematic profile as of Nov 18, 2026, and the comparison is rated Competitive — 3 of 5 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.

Why does the AIQ Score favor PHG over PRCT?

The composite weights Quality, Value, Momentum and Risk Resilience. PHG leads Value by 42 points; PHG leads Risk Resilience by 28 points; PHG leads Quality by 22 points. PHG leads on all four AIQ factor dimensions. Value is itself one of those four, so the sweep is not explained by PRCT simply being cheaper — it warrants extra scrutiny for unmodeled catalysts, forward expectations or event risk the factors do not capture.

Which has more analyst upside, PHG or PRCT?

Analyst price targets imply not covered upside for PHG and +19.1% for PRCT. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, PHG or PRCT?

PHG is the better-valued of the two on the peer-relative Value factor. PHG on the peer-relative Value factor, by 42 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, PHG or PRCT?

PRCT on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, PHG or PRCT?

PHG on the Momentum factor, by 12 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, PHG or PRCT?

PHG is the more resilient of the two, so the other name carries the higher downside risk. PHG on Risk Resilience, by 28 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is PHG more profitable than PRCT?

The profitability evidence is mixed: gross margin 46.4% vs 64.7%; operating margin 10.9% vs -33.6%; ttm roe 0.2% vs -8.1%. Each name leads on one measure, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.

Is PHG's lead over PRCT getting stronger or weaker?

PHG lead: Strengthening — the AIQ differential moved from 18 to 23 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-06-01 and 2026-11-18. The lead has not changed hands in that window.

What would change the PHG vs PRCT verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: PRCT closes the Value gap — currently 42 points behind, the largest single contributor to PHG's edge; PRCT's Death Cross Active resolves — a bearish trend rule currently active against it; PHG's conflicting signal state resolves bearish — it currently carries 3 bullish and 2 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about PHG and PRCT?

PHG: 3 bullish / 2 bearish / 1 neutral, conflicted. PRCT: 4 bullish / 1 bearish / 2 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on PHG is Death Cross Active (bearish, long horizon). On PRCT it is Death Cross Active (bearish, long horizon).

Compare PHG and PRCT with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.